The development of live attenuated cold-adapted influenza virus vaccine for humans (Q33782441)

29 July 2017

1 reference

title

The development of live attenuated cold-adapted influenza virus vaccine for humans (English)

1 reference

29 July 2017

1 reference

1 reference

Maassab HF

1

1 reference

PubMed ID

10578119

29 July 2017

Bryant ML

series ordinal

2

1 reference

29 July 2017

1 October 1999

1 reference

Reviews in Medical Virology

29 July 2017

1 reference

29 July 2017

9

1 reference

29 July 2017

237-244

1 reference

29 July 2017

4

1 reference

Serious morbidity and mortality associated with influenza epidemics

29 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C237%3A%3AAID-RMV252%3E3.0.CO%3B2-G

Immunity to influenza in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C237%3A%3AAID-RMV252%3E3.0.CO%3B2-G

Analysis of antigenic drift in recently isolated influenza A (H1N1) viruses using monoclonal antibody preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C237%3A%3AAID-RMV252%3E3.0.CO%3B2-G

Effect of live attenuated, cold recombinant (CR) influenza virus vaccines on pulmonary function in healthy and asthmatic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C237%3A%3AAID-RMV252%3E3.0.CO%3B2-G

Development and characterization of cold-adapted viruses for use as live virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C237%3A%3AAID-RMV252%3E3.0.CO%3B2-G

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C237%3A%3AAID-RMV252%3E3.0.CO%3B2-G

Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C237%3A%3AAID-RMV252%3E3.0.CO%3B2-G

Superiority of live attenuated compared with inactivated influenza A virus vaccines in older, chronically ill adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C237%3A%3AAID-RMV252%3E3.0.CO%3B2-G

Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C237%3A%3AAID-RMV252%3E3.0.CO%3B2-G

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C237%3A%3AAID-RMV252%3E3.0.CO%3B2-G

Reverse Genetics Meets the Nonsegmented Negative-Strand RNA Viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C237%3A%3AAID-RMV252%3E3.0.CO%3B2-G

Identification of another epidemic respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C237%3A%3AAID-RMV252%3E3.0.CO%3B2-G

Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C237%3A%3AAID-RMV252%3E3.0.CO%3B2-G

Maternal mortality in the epidemic of Asian influenza, New York City, 1957.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C237%3A%3AAID-RMV252%3E3.0.CO%3B2-G

Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C237%3A%3AAID-RMV252%3E3.0.CO%3B2-G

Comparison of live and inactivated influenza vaccine in high risk children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C237%3A%3AAID-RMV252%3E3.0.CO%3B2-G

Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C237%3A%3AAID-RMV252%3E3.0.CO%3B2-G

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C237%3A%3AAID-RMV252%3E3.0.CO%3B2-G

10.1002/(SICI)1099-1654(199910/12)9:4<237::AID-RMV252>3.0.CO;2-G

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10578119